CoapTech

CoapTech manufactures the PUMA-G System, the FDA-cleared ultrasound-guided percutaneous gastrostomy (PUG) solution for bedside feeding tube placement in critical care and acute care settings. The system enables physicians and advanced practice providers to perform gastrostomy procedures at the patient bedside using ultrasound visualization, eliminating the need for operating room scheduling, endoscopic reprocessing, or fluoroscopy exposure. Clinical evidence demonstrates significant hospital cost reductions (up to $34,778 per patient) and shortened ICU length of stay (5–10 days) compared to traditional PEG or PRG procedures. The PUMA-G System is deployed in ICUs, step-down units, floor units, interventional radiology suites, and long-term acute care hospitals. The system reduces procedural risks including organ perforation from blind sticks, infection from endoscope reprocessing, and radiation exposure from fluoroscopy. Key clinical applications include COVID-19 patient care (tandem tracheostomy–gastrostomy procedures) and integration into critical care teams to optimize patient throughput and procedural efficiency. CoapTech holds FDA 510(k) clearance and serves tertiary care centers, academic medical centers, community hospitals, and for-profit hospital systems across the United States.